Parallel Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Parallel Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-95	Closed	-$1K	–	3438
2022 Q1	$1K	Buy	+95	New	+$1.27K	﹤0.01%	2886
2021 Q4	–	Sell	-700	Closed	-$22K	–	3349
2021 Q3	$22K	Hold	700	–	–	﹤0.01%	1697
2021 Q2	$29K	Buy	+700	New	+$28.8K	﹤0.01%	1500

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Parallel Advisors's DMTK Position: Q2 2022 in Review

Parallel Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 95 shares — an estimated $1K sold.

Parallel Advisors first reported a position in DMTK in Q2 2021 and held it in 3 quarters. The position peaked at $29K in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

Parallel Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Parallel Advisors sold 95 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $1K.
Parallel Advisors first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Parallel Advisors's DermTech, Inc. Common Stock position peaked at $29K in Q2 2021.
134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.